AI Science Tracker
EN

Generative AI-driven de novo design of high-affinity, epitope-specific antibodies targeting the CD93-IGFBP7 axis for cancer immunotherapy.

Affiliation not stated in the reviewed material · 28 Apr 2026 · medicine

Discovery

Generative AI-driven de novo design of high-affinity, epitope-specific antibodies targeting the CD93-IGFBP7 axis for cancer immunotherapy.

Source check: Source checked. Not independent scientific confirmation.

Finding / tested result: Generative AI contributed a candidate antibody that showed measured target binding/blockade and tumor-model activity; the evidence is preclinical and does not establish human efficacy.

Technology: A generative AI model designed candidates for a target interface; the lead was selected and tested experimentally. No sequence or operational design details reproduced.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
A generative AI model designed candidates for a target interface; the lead was selected and tested experimentally. No sequence or operational design details reproduced.
Limitation / still unknown
Biophysical binding, cell-based blocking and tumor-model experiments tested the candidate. This is preclinical evidence, not human or clinical validation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://academic.oup.com/abt/article/9/3/323/8664001 · https://europepmc.org/article/MED/42592032

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.